Hormone therapy risks are lower for women close to menopause

02/19/2010 | Medscape (free registration)

The benefit-risk profile for hormone therapy is better for women close to menopause but decreases over time as women age, according to a position statement by the North American Menopause Society. The updated guidelines include new sections on discontinuing HT and HT and ovarian and lung cancer.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN